Page 174 - Aet News Today

Three senators recently introduced legislation that would ban the use of health data for advertising and marketing purposes. The proposed legislation comes amid media reports claiming that data brokers are selling social media companies patients' location data, as well as reports that hospitals and digital health startups are collecting patients’ online data and sharing it with tech giants such as Facebook and Google.

Through the partnership, Signify Health clinicians will be able to use Cardinal's OutcomesOne platform and perform an in-home, CMS-compliant medication review to determine which members are not taking their medications as prescribed and address those needs.

Before healthcare providers onboard workers sourced from staffing agencies, they should make sure these laborers are hired as W-2 employees rather than 1099 independent contractors, one lawyer recently warned. The Department of Labor is increasing its efforts to ensure healthcare facilities are complying with the law as it pertains to contract labor and overtime pay.

By the end of March, Medicaid/CHIP enrollment will have grown by 23.3 million members since the start of the pandemic, according to a Kaiser Family Foundation report. This is largely due to the continuous enrollment provision enacted during the pandemic, which barred states from disenrolling members and is set to expire March 31.

The FBI, CISA and HHS have all recently issued warnings about the dangers associated with the Royal Ransomware gang. Since approximately September of last year, cybercriminals have been using a Royal ransomware variant to compromise organizations across the U.S., many of which have been healthcare providers.

By combining some old-fashioned hand-holding (i.e., navigators) with some familiar technology (i.e. texting), we could save patients and their loved ones needless worry, money, and time. Equally importantly, we could reduce needless re-admissions.

If the NSA-implementing agencies could plot out and publish their plan for adopting standards, publishing regulations, and setting new compliance dates for the NSA AEOB and provider directory requirements, it would help tremendously to level set on expectations and help organizations budget and plan for actual implementation.

BioMarin Pharmaceutical's submission of additional data for patients treated with its hemophilia A gene therapy, Roctavian, mean that the FDA will push out a regulatory decision to early summer. But it could be worth the wait as analysts anticipate FDA approval and project Roctavian becoming one of BioMarin’s biggest products.

Adaptimmune and TCR2 Therapeutics have complementary technologies and an aligned strategy of developing cell therapies for solid tumors, but this marriage is preceded by divorce. Before consummating the TCR2 deal, Adaptimmune ended an alliance with a larger pharmaceutical company.

While they’ve always served as hubs for medication and other basic necessities, now is the time to innovate and remove the burden from the healthcare system. It’s time for pharmacies to become central locations for all things health and wellness– diagnostics included.